Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferric glycinate is an iron amino acid chelate consisting of iron in the ferric (Fe3+) oxidation state complexed with glycine. It is used as an oral iron supplement for the treatment and prevention of iron deficiency and iron deficiency anemia. By chelating the iron atom with amino acids, the compound is intended to be more stable in the gastrointestinal tract, potentially leading to improved absorption and reduced gastrointestinal irritation compared to traditional inorganic iron salts like ferrous sulfate. In clinical studies, it has been evaluated for its tolerability profile relative to other iron formulations, such as ferrous bisglycinate and ferrous sulfate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferric glycinate.